Simon Eschweiler - Concepedia

Author

Simon Eschweiler

La Jolla Institute for Immunology ORCID

Also Known As

S Eschweiler, Simon Eschweiler

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

La Jolla Institute for Immunology University of Southampton University of California San Diego University Hospital Southampton NHS Foundation Trust University of Liverpool

About

Simon Eschweiler is an author at La Jolla Institute for Immunology specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	715
2	Immunology	3	3	715
3	Autoimmunity	2	2	133
4	Immune Cell Development	1	1	29
5	Immune Regulation	1	1	29

Simon Eschweiler

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19 Benjamin J. Meckiff, Ciro Ramírez-Suástegui, Vicente Fajardo, Cell T-regulatory CellCovid-19 PandemicImmunologyCellular Immune ResponseMedicine	2020	582
Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer James Clarke, Bharat Panwar, Ariel Madrigal, The Journal of Experimental Medicine	2019	251
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy Simon Eschweiler, James Clarke, Ciro Ramírez-Suástegui, Nature Immunology Cancer ImmunosurveillanceT-regulatory CellImmunologyAutoimmunityAnti-pd-1 Treatment Efficacy	2021	104
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs Simon Eschweiler, Ciro Ramírez-Suástegui, Yingcong Li, Nature	2022	79
IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants Yannic C. Bartsch, Simon Eschweiler, Alexei Leliavski, Journal of Allergy and Clinical Immunology	2020	62
Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis Julia Pagel, A. Hartz, Julia Figge, Clinical & Experimental Immunology InflammationClinical Early-onset SepsisMaternal ImmunizationAdaptive Immune SystemImmune Cell Development	2016	29
JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells Simon Eschweiler, Alice Wang, Ciro Ramírez-Suástegui, Cell Reports	2023	16
CD4 <sup>+</sup> follicular helper-like T cells are key players in anti-tumor immunity Divya Singh, AP Ganesan, Bharat Panwar,	2020	13

Page 1